Cite
HARVARD Citation
Richards, D. et al. (n.d.). P390 Ustekinumab modulates IL-12 and IL-23-related cell type-specific inflammatory transcriptional states in Ulcerative Colitis induction therapy. Journal of Crohn's and colitis. p. i523. [Online].